Overview

Candidate Pre Phase 1 Phase 2 Phase 3

PRO 140

Pre-Clinical Phase completed
Phase 1 completed
Phase 2 completed
Phase 3 in progress

CytoFeline

Pre-Clinical Phase completed
Phase 1 completed
Phase 2 in progress
Phase 3 not started

Cytolin

Pre-Clinical Phase in progress

PRO 140

PRO 140 is a fully humanized monoclonal antibody which is a cellular targeting CCR5 entry antagonist recently acquired from Progenics Pharmaceuticals.

Read more about PRO 140 ...

CytoFeline

This virus is a member of the Lentivirus subfamily of Retroviruses.

Read more about CytoFeline ...

Cytolin®

Cytolin® is a mouse monoclonal antibody that was originally developed to identify a specific type of immune cell called a cytotoxic T cell, or CTL.

Read more about Cytolin® ...